“Wake-up call” unheeded as Canadian VC investment hits lowest level since H1 2020
CVCA report finds life sciences, venture debt among bright spots in otherwise bleak H1 2025.
CVCA report finds life sciences, venture debt among bright spots in otherwise bleak H1 2025.
Plus: Trade war uncertainty has some Canadian startups “hanging by a thread.”
Drouin is departing the angel investor network for personal reasons less than a year after taking the helm.
Vancouver VC firm is targeting a final close totalling $250 million within the next year.
Northleaf has raised $908 million CAD for its fourth secondary fund at the perfect time.
Aidan Gomez-backed startup still unsure if it will follow Cohere CEO’s advice on remaining in Canada.
Canadian team members Saar Pikar, Laura Lenz take on new roles as US investment team shrinks.
Q4 Inc.’s Darrell Heaps on treating liquidity as a strategy, not a finish line.
Plus: The pressure to adopt AI has created a “Wild West” for corporate cybersecurity.
Business Loan Accelerator Program aims to expand BDC’s reach to more underserved founders in Canada.
SRTX and Oomira founder says “nothing in the term sheet is in your favour.”
NBIF becomes LP as Toronto firm dips its toes into institutional investor pool.
A persistently cool exit market and middling returns are preventing cash from re-entering the market, data shows.
Investors say proving long-term differentiation is more important than ever as AI saturates the market.
Canadian execs report uneven efficiency gains from AI and a lack of technical talent, Georgian survey finds.